(Q38082553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Recombinant production of proteoglycans and their bioactive domains (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

John Whitelock

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

Megan S Lord

1 reference

28 August 2017

2

John M Whitelock

1 reference

28 August 2017

language of work or name

English

0 references

publication date

18 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

2490-2510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Purification and characterization of a recombinant human testican-2 expressed in baculovirus-infected Sf9 insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mammalian cell protein expression for biopharmaceutical production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Heparan sulfate biosynthesis: methods for investigation of the heparanosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Heparan sulfate: a complex polymer charged with biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Leucine-rich repeat glycoproteins of the extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Recombinant decorin glycoforms. Purification and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Fibromodulin and lumican bind to the same region on collagen type I fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Real-time monitoring of the adherence of Streptococcus anginosus group bacteria to extracellular matrix decorin and biglycan proteoglycans in biofilm formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The production and purification of functional decorin in a baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin core protein secretion is regulated by N-linked oligosaccharide and glycosaminoglycan additions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

An antimetastatic role for decorin in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin attenuates gliotic scar formation in the rat cerebral hemisphere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Eukaryotic expression of recombinant biglycan. Post-translational processing and the importance of secondary structure for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Different usage of the glycosaminoglycan attachment sites of biglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Interaction of biglycan with type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Construction and expression of a functional recombinant gene for proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Two alanines juxtaposed to aggrecan's G1 domain alter its intracellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Identification of hyaluronan-binding domains of aggrecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The folded modules of aggrecan G3 domain exert two separable functions in glycosaminoglycan modification and product secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Heparan sulphate proteoglycans interact with neurocan and promote neurite outgrowth from cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Versican: a versatile extracellular matrix proteoglycan in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Cell adhesion and proliferation mediated through the G1 domain of versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The versican C-type lectin domain recognizes the adhesion protein tenascin-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Versican G1 domain and V3 isoform overexpression results in increased chondrogenesis in the developing chick limb in ovo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Calcium-dependent self-association of the C-type lectin domain of versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Bikunin--not just a plasma proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Structural analysis of bikunin glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

High level expression of bikunin in Pichia pastoris by fusion of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression and purification of active recombinant human bikunin in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression of rat alpha 1-microglobulin-bikunin in baculovirus-transformed insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Intracellular coupling of bikunin and the heavy chain of rat pre-alpha-inhibitor in COS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Nidogen-2: a new basement membrane protein with diverse binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Recombinant human collagen XV regulates cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Molecular polymorphism of the syndecans. Identification of a hypo-glycanated murine syndecan-1 splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin α3 LG45 protein domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Structural determinants of heparan sulfate interactions with Slit proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

S-Nitrosylation of secreted recombinant human glypican-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Heparan sulfate composition of alternatively spliced CD44 fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

CSPG4 in cancer: multiple roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Protein core-dependent glycosaminoglycan modification and glycosaminoglycan-dependent polarized sorting in epithelial Madin-Darby canine kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

Utilization of a Recombinant Substrate rAgg1 to Study the Biochemical Properties of Aggrecanase in Cell Culture Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12197

21 January 2018

Identifiers

DOI

10.1111/FEBS.12197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419186%20AND%20SRC:MED&resulttype=core&format=json